Erectile dysfunction is an issue that plenty of men deal with. And while there are lots of pills and creams out there that promise to help you maintain an erection and last longer in bed, it can be hard to figure out which one is best for you.

Luckily there are a number of science-backed solutions out there that promise stronger, longer erections without negative side effects. So we looked at 3 of the most popular solutions on the market: MV.Health’s Tenuto 2, a constrictive device, and PDE5 inhibitors (aka the “little blue pill”). Scroll down to see how we scored them and which we think is the winner.

How They Work

The Tenuto 2 is a wearable medical vibrator that helps you get erect and stay erect by increasing blood flow and sending powerful, targeted vibrations through your penis and perineum. The vibrations stimulate your partner as well, and the device can be controlled via a smart app.

Constrictive devices are generally silicone or plastic rings that sit at the base of the penis. They slow the blood flow back from the erect penis, allowing it to stay erect longer. However they can’t help with getting erect.

PDE5 inhibitors are taken orally and work to block the phosphodiesterase type 5 (PDE5) enzyme that can prevent an erection. These medications can help to relax muscles and arteries inside the penis, allowing more blood to reach the penis. They can be taken 30 mins to 4 hrs before sexual activity.

Science

The Tenuto 2 is heavy on the tech and is an FDA Class 2 device designed by leading Urologists. It has 4 power motors with 16 intensities. It comes with 8 preset vibration patterns, and you can also create your own patterns using the App.

As with any medication, years of scientific research and testing went into the creation of PDE5 inhibitors.

A constrictive device is literally just a silicone ring, so no tech there.

This category is a tie between Tenuto 2 & PDE5 inhibitors.

Comfort

We’re focusing on the wearable devices for this category since comfort doesn’t come into play with the PDE5 inhibitors.

Most constrictive devices slip on easily. However for them to be effective they need to be tight. As a result, many users complain of pinching or discomfort, especially if used for a long time. Also it makes it hard to ejaculate with constriction devices on. Many brands offer different sizing, so you can figure out which is best for you.

The Tenuto 2 is much more advanced. It comes in one size that is super flexible & stretches to fit all penis sizes. So you don’t need to buy many sizes or worry about it not fitting. The soft stretchy material makes it comfortably snug. When you turn on the vibration under the perineum, it feels particularly good.

This category goes to Tenuto 2.

Side Effects

Because you simply slip them on and off, the Tenuto 2 and constrictive devices have no side effects.

PDE5 inhibitors are a different story. Headaches, skin flushing, and upset stomach are common side effects. Nose bleeds and a stuffy nose can also occur. And we’ve all heard the warning about “an erection lasting longer than 4 hours” at the end of the commercials. It’s rare, but it can happen.

Tie between Tenuto 2 and constrictive devices.

Impact on Intercourse

The Tenuto 2 and PDE5 Inhibitors help you get erect and stay erect, while constriction devices only help stay erect but not getting erect.

Sex with PDE5 inhibitors and constrictive devices on the other hand, is just sex. And yes, we know the saying. Sex is like pizza. Even if it's bad, it's still pretty good. And we agree.

On the other hand, Tenuto 2 offers 360-stimulation for your partner, leading to earth-shattering orgasms - supercharging your sex.

No contest here - point Tenuto 2.

Price

Normally we’d give this category to the product with the lowest price. Constrictive devices can be cheap, but we’ve seen prices as high as $600! The cost of PDE5 inhibitors will vary depending on your insurance, but generic PDE5 inhibitors can start at $8.50 a pill, which again adds up to $600 or more in a year even if you only buy a few pills a week.

In comparison, the tech-filled Tenuto 2 is a one-time cost of only $223 and comes with a 2 year, no questions asked, warranty!

With all of the technology in the Tenuto, plus the fact that it’s the only solution that can help you get erect, stay erect and stimulate your partner, all at the same time, we think $223 is a very reasonable price. So in terms of what you get for your money, the Tenuto wins in a landslide.

Conclusion

While the Tenuto 2, PDE5 inhibitors, and constriction devices are all good options to help you with erections, our clear winner is MV.Health’s Tenuto 2. The constriction devices are certainly a smaller option, and PDE5 inhibitors are discreet, but the Tenuto 2 just enhances the sexual experience all around.

The vibrations take sex to the next level for both you and your partner and the ergonomic design stretches to fit your penis perfectly. Not only does it solve ED, it also intensifies sex and, as a happy customer puts it, “experience the ultimate couple climax & your partner's gratefulness, over & over again.”

UPDATE: MV.Health has extended a special offer to our readers. For a limited-time Save 30% on the Tenuto 2

When you're in the prime of your life, it’s easy to feel invincible about many things, including your health. And with so much to worry about, why bother prioritizing something like prostate health? After all, that's an issue for aging, right? Wrong. Prostate issues contribute to pain, pressure, and even ED - at any age. That’s why being proactive about prostate health is important now. What if we told you that being proactive about your health could be pleasurable? Here’s the thing: it is – with the right tool for the job. When it comes to pleasurable prevention, the doctor-designed prostate vibrator Molto is a game-changer for men’s health and wellness. Not what you were expecting to hear? Here are 6 unexpected ways this prostate vibrator not only keeps you ahead in the health game.

1. Reduce The Risk Of Prostate Cancer

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime, making it the 2nd most common cancer after skin cancer. While there are certain risk factors, like genetics, that you can’t control, you can be proactive about your prostate health with the help of Molto in a few unexpected ways. Here’s the context: a 2016 study found that men who ejaculated an average of 21 times per month had a lower risk of developing prostate cancer than those who ejaculated less than that. So why exactly does ejaculating frequently work to reduce prostate cancer? It’s because ejaculation eliminates prostatic fluid buildup, keeping the prostate gland healthy and functioning. Prostate massage with Molto’s therapeutic vibrations can aid in releasing a buildup of fluid in a minimally non-invasive way. Molto offers a customizable way to find the pressure that works for you with targeted vibrations, 16 different intensity levels, and a catalog of pre-programmed patterns. Additionally, its ultra-slim design makes it easy for beginners to be proactive about prostate health and explore the profound benefits of prostate massage.

2. Increase Your Pleasure With Prostate Orgasms

The prostate, often hailed as the male 'G-spot,' is capable of catapulting male pleasure to unprecedented levels. Prostate orgasms, distinct from their penile counterparts, offer a deeper, more intense sensation described in a Man of Man review as a whole-body "orgasm bomb.” Molto is designed to target and stimulate the P-spot with powerful targeted vibrations, offering men a new way to explore and discover these sensational experiences. Additionally, its sleek and user-friendly design makes exploring your P-spot more like playing your favorite game—exciting, rewarding, and with plenty of surprises along the way. Bend Molto’s flexible and slim neck to position the motor exactly where you want it, whether directly on your prostate or to other areas of the anus, which is also riddled with sensitive nerve-endings. Bendability allows you to move with Molto, finding out which positions work best for your anatomy. Coupled with powerful vibrations, Molto has a slew of different vibe patterns and 16 different speeds, making it fully customizable. Beginner-friendly and ultra-slim, it’s easy to grip in one hand and easy to use with large tactile buttons. Now, this is a proactive pleasure design we can get behind!

3. Prevent Prostate Inflammation And Pressure

Prostatitis, or prostate inflammation, isn't just uncomfortable; it’s downright painful and can happen at any age. Prostatitis is like having that one annoying guest at a party who just won’t leave — it can be a real pain and tends to affect everything else around it, like your prostate, pelvis, and groin, which can make sitting, standing, or daily life difficult. Prostate inflammation can occur for many reasons, but one being a buildup of prostatic fluid that needs to be released but may need a helping hand. Traditional methods of treating prostate inflammation involve going to the urologist manually massaging the area with their finger. This is why Molto is designed to be the width of a finger and mimic the movements of a doctor’s finger. With medically optimized vibrations that massage the prostate’s tissues, Molto can help release and prevent the buildup of fluids that leads to inflammation and pressure. This way, you have an at-home preventive measure to safeguard against prostate issues as well as a comfortable way to maintain prostate health in privacy.

4. Improve the Potency of Your Ejaculations by Removing Prostate Fluid Buildup

Don’t let the pressure of prostate fluid blockages get in the way of your pleasure. If you didn’t know, the prostate is responsible for producing semen, so a healthy prostate is paramount to reproductive health, and a kink in the piping (and not the good kind of kink) can make things, well, anticlimactic. Molto's gentle, targeted vibrations with 16 different speeds can help remove and reduce fluid blockages, easing pressure that can come when you do. By stimulating the prostate, you can relieve the pressure of fluid blockages and inflammation that can cause ejaculation issues. In this way, Molto can significantly increase the intensity of your finish or recover intensity lost to prostate issues.

5. Boost Blood Flow for Healthier Prostate Function

Optimal prostate health starts with proper blood flow, a critical factor often overlooked and underplayed. Healthy blood flow to and from the prostate not only keeps the tissue healthy but allows it to function properly, like producing semen and maintaining your reproductive health. And you know what is scientifically proven to improve blood flow? Vibrations. With Molto, vibrations can be applied directly to the prostate, providing you with a health boost. This ultra-slim prostate vibrator is not only powerfully pleasurable but flexible because the prostate is located at an angle in the anus. Molto can be bent to find your prostate and send targeted vibrations from its powerful motor right where you need them, giving you a pump that you don’t need to go to the gym to get.

6. Keep Your Urination Flow Fluid

Ever stood over the porcelain throne and had an issue starting the stream? Most men don’t realize that trouble starting or completing urination can be a sign of prostate issues. An enlarged or swollen prostate can constrict the urethra, turning what should be a straightforward task into an awkward bathroom dance. Keep your plumbing in peak condition with the help of the Molto. The stimulating vibrations from this prostate vibrator can help reduce swelling by clearing the piping, aka your prostatic duct, promoting a more fluid flow. Molto’s ergonomic size makes it easy to hold and operate in one hand so your private moments can be kept private.

When it comes to improving prostate health and pleasure, it's clear that Molto isn't just another vibrator in the drawer; it's a doctor-designed preventative powerhouse packing both pleasure and health benefits. From boosting blood flow, keeping your fluids flowing, and the grand finale of a strong finish, Molto offers an experience that’s hard to pass up. After all, who said preventative care couldn’t be pleasurable!

Molto Features

• Molto features one 1 powerful motor that sends precise, targeted vibrations directly to the prostate or anywhere in the anus or vagina you desire.

• Innovative ultra-flexible neck that can bend to accommodate different body shapes and prostate positions within the body.

• 100% showerproof

• Made from medical body-safe silicone.

• FDA-registered class II medical device

• FSA/HSA eligible

• Doctor-designed by leading Urologists.

• Easy to hold and control with one hand.

• 16 vibration settings give you the ultimate control of your anal adventures.

• 8 pre-set vibration patterns and access to a catalog of vibration patterns with the free smartphone app.

• Eco-friendly and sustainable. USB rechargeable battery.

• Smartphone compatible to control remotely up to 10 meters/30 feet.

• Compatible with the free smart app to create and save personalized vibration patterns.

• Doctor-recommended to help with a range of prostate health issues.

• Can be used by anyone of any gender or orientation.

Save up to 30% on the Molto when you shop MV.Health’s Big Summer Sale today!

I started experiencing ED a few years ago when I hit my early 40s. And of course, I experienced all the emotions that go along with that - lower confidence, anxiety around intimacy, and even some slight depression. I tried to just avoid the topic and hope that it was a blip that would correct itself within a few months. But once it became clear that it wasn’t just a passing thing, my partner encouraged me to look into options that would help us get our intimacy back on track. I had only really heard of pills like Viagra to help with ED, so when my doctor prescribed those, I just accepted it as the only solution.

And they worked. Kind of.

I dealt with some mild side effects, like headaches and slight nausea, but at least I was able to perform again, I told myself. However, there was one thing with the pills that really frustrated me. The timing. I hated that I had to wait at least 30 minutes for them to start working - so much for spur of the moment romance. And I also hated that sometimes they started working too early - like the time my partner and I were out for a nice dinner and I developed an erection that forced us to awkwardly sit at our table long after we’d paid the bill. I felt like a teenage boy who couldn’t get up from his desk when the bell rang for the next class. Mortifying. It always seemed like I was rolling the dice when I popped that little blue pill.

Finally, I got fed up and decided to do some research. There had to be a better option. That’s when I came across MV.Health, a company that makes award winning smart sex toys for men, women & couples. With a focus on keeping the mystery in the bedroom, they offer high tech vibrators designed to help with ED and other sexual health issues.

I took the quick but thorough quiz offered on their website and based on my answers they recommended the Tenuto 2, which promised a “confidence boost in intimate moments.” The Tenuto offers vibration stimulation to the penis and pelvic floor, which is a proven solution to ED. The device also had great reviews from customers who also struggled with similar issues. So I placed an order and tried to wait patiently.

The order arrived quickly and was really discreet - I wasn’t embarrassed about ordering a vibrator but we also didn’t necessarily want to announce it to all the neighbors. I was impressed by the sleek, modern packaging and design. It felt a little bit like unboxing an iPhone.

I’ll be completely honest, when I had gotten the Tenuto out of the box, it was a little intimidating. I wasn’t quite sure where to put what, but after a quick review of the instructions, it became very clear how to use it. The flexible ring can fit almost any penis size and there’s a piece that rests along the perineum. The Tenuto has 4 anatomically placed motors, 16 intensity levels, and 8 preset vibration patterns. So basically stimulation everywhere.

That night I was excited to surprise my partner with the Tenuto, but I was a bit nervous. What if it didn’t work as well as promised? Was I setting myself up for disappointment? I got my parts situated properly and switched on one of the preset vibration patterns. Immediately I felt lightning bolts shoot through my body. My penis quickly stood at attention. As my partner and I got down to business, it was clear that she was enjoying the Tenuto as much as I was. MV.Health says that their products are designed for “your ultimate erection and your partner’s gratefulness.” And after just a few minutes I could tell that they had indeed achieved this lofty goal.

I won’t go into much more detail here but I’ll just say that my concerns about being disappointed were completely unfounded. The post-coital reverberations lasted long after the explosive orgasms. We lay trying to recover, and I wondered how we had lived without the Tenuto, even before ED. And based on the fact that she was trying to catch her breath minutes later, I was confident that my partner was thinking something similar.

There’s a lot that I love about the Tenuto, but I think my favorite thing is that it’s ready to go whenever I am. No popping a pill and hoping for the best. No more missing out on passionate spur of the moment encounters. And no more embarrassing public displays of erection.

Long story short, Tenuto has completely changed our sex life. Gone are my insecurities about ED and my ability to perform. Gone are awkward intimate moments where I feel like I’m letting my partner down. And gone are the side effects from Viagra. I know this might sound crazy, but I think I’m actually grateful for the ED - without it I wouldn’t have discovered MV.Health, and we wouldn’t have found this simple way to bring back the intimacy and excitement to our love life. If you’ve been taking pills for ED and are ready for a better solution that’s ready when you are, MV.Health’s Tenuto is exactly what you need. Just trust me on this one.

For a limited time save 35% on the Tenuto 2 when you shop on MV.Health today!

For men dealing with erectile dysfunction (ED), choosing the right solution can be challenging. While traditional ED pills are widely known, they aren’t the only option. Tenuto 2 by MV.Health offers an innovative, non-medicinal alternative with unique benefits. Before you reach for a pill, here’s why you should consider this wearable ED solution, dubbed the “Tesla of Vibrators” by Vice. Tenuto 2 doesn’t just fight ED—it revolutionizes performance, offering a natural, customizable experience that pills simply can’t match.

Limited Time Offer: Save 30% on the Tenuto 2

Tenuto 2 vs. ED Pills: Which ED Solution is Best?

1. Clinically Proven Technology vs. Traditional Chemistry

• While ED Pills relies on chemistry to inhibit the PDE5 enzyme, allowing more blood flow to the penis, Tenuto 2 takes a different, natural approach. This wearable device has four motors that send powerful vibrations to the penis and perineum, which increases blood flow and arousal without relying on medications or risking side effects. Its snug yet comfortable fit restricts blood where you want it, helping you last longer.

• It’s clinically proven to improve ED, making it a powerhouse for performance. With advanced, app-enabled controls, you can customize Tenuto 2’s vibrations to your preference, setting intensities and patterns to suit your needs and optimize arousal.

• This means you get a personalized experience tailored specifically to you, unlike the one-size-fits-all nature of pills.

2. A Natural, Side-Effect-Free Experience

• ED Pills, though effective, often comes with a list of side effects, including headaches, flushing, upset stomach, and nasal congestion. There’s also the rare but serious risk of a prolonged erection. Tenuto 2, on the other hand, is entirely natural—no chemicals, no prescriptions, and no unwanted side effects.

• Its wearable design means it’s easy to put on and take off, allowing you to enjoy intimacy without worrying about how your body might react.

• This natural approach ensures you can focus on the moment without distractions or concerns.

3. Increased Partner Intimacy and Personalization

• Tenuto 2 stands out for its ability to improve partner intimacy beyond helping with ED. The three front motors deliver stimulation to both partners at the same time, ensuring the entire experience is mutually beneficial.

• Additionally, Tenuto 2 offers personalization in a way few devices do. Using the app, you can control each of the four motors’ intensity, pattern, and vibration settings, allowing you and your partner to tailor the experience in real-time.

• This precision control transforms intimacy into an interactive experience that pills simply can’t provide.

4. Doctor-Designed and Built to Improve Performance

• Designed with leading urologists, Tenuto 2 is specifically made to enhance male performance. It’s been clinically proven to improve ED, earning the doctor’s stamp of approval.

• Its soft, flexible material stretches comfortably to fit all penis sizes, providing a snug yet comfortable experience that feels natural and supportive. Each element is crafted to maximize efficacy, delivering both targeted stimulation and comprehensive support.

• This means you’re using a device that’s not only effective but also trusted by medical professionals.

5. Value and Long-Term Savings

• Though Tenuto 2’s one-time cost of $329 may seem high upfront, it quickly becomes more economical than consistently buying ED Pills, which can cost upwards of $800 annually. With Tenuto 2, you’re making a single investment in an effective, sustainable solution that lasts years and includes a two-year warranty for peace of mind.

• You can order it discreetly online without dealing with doctors or prescriptions, saving both time and money.

• Investing in Tenuto 2 is not just a purchase—it’s a long-term assurance for improved intimacy and performance.

Why Tenuto 2 Is the Clear Winner

• For men seeking an ED solution, Tenuto 2’s clinically proven, wearable technology offers something that no pill can: control, versatility, and a personalized experience that enhances intimacy for both partners.

• It’s not just about achieving an erection—it’s about elevating the entire experience, from performance to connection.

• With Tenuto 2, you’re not just addressing a problem; you’re embracing a solution that enriches your intimate life.

Ready for a doctor-recommended, side-effect-free solution? Then Tenuto 2 is it. Experience the difference of a device that’s been called the “Tesla of Vibrators” and discover a new level of intimacy and performance.

UPDATE: MV.Health has extended a special offer to our readers. For a limited-time Save 30% on the Tenuto 2

When I hit my 40s, I began to notice a decline in my, how shall I say, performance in the bedroom. Erections were harder to come by (no pun intended) and when I was able to get it up, I couldn’t maintain it for long. I knew that ED is common in men over 40, but I also had a lot going on in my life - busy job, kids, and general stress about the state of the world.

So, my initial thought was that all this anxiety was causing the problems and it would go away. But after a few months, the ED was getting noticeably worse and I decided to do something about it. My first course of action was doing research online. I didn’t really want to go to the doctor and bringing it up at a boys’ night wasn’t an option. I assumed that Viagra would be the route I’d have to take, but I wanted to find a solution without the side effects of headaches, upset stomach, or 4-hour erections. UPDATE: MV.Health has extended a special offer to our readers.

For a limited-time Save 30% on the Tenuto 2.

It was during this initial search when I came across a brand called MV.Health. The company uses the latest advances in medical technology, material science, and sexual health research to design devices that address major issues like ED, pain and arousal. So, I took the quiz on their website to see which product would work best for me.

Based on my answers they recommended the Tenuto 2, which is designed to help “get erect, stay erect, supercharge performance & have long lasting sex.” I was skeptical. If this thing was really this good, why hadn’t I heard of it before? Then I remembered that most guys, myself included, don’t want to broadcast their ED struggles to the world.

After doing some more research on the Tenuto 2, my interest was piqued. The product is really impressive. It was designed by leading urologists, backed by a decade of research, won over 30 awards, FDA registered, clinically proven to improve erection by 2x within 5 weeks. And after reading the endorsements (one actually said, “Tenuto is…HEAVEN.”) and seeing it’s endorsed by from Mayo Clinic & Cedars-Sinai, I was convinced to place an order.

The package arrived quickly and discreetly. To be honest, I was embarrassed about ordering a vibrator and didn’t want to announce it to all the neighbors, but with the inconspicuous packaging, there was no worry of that.

I opened my order and was impressed by the sleek, modern packaging and design. It felt a little bit like unboxing an iPhone. I got the Tenuto 2 out of the box and it was beautiful to hold. After a quick review of the instructions, it was easy to get on.

The flexible front of Tenuto 2 can fit all penis sizes and the back part stimulates the perineum. When you first put it on, it takes a minute to get used to. That night my wife and I decided to give it a try. She had never made any comments about my ED, but I knew that it was affecting her, so I was hopeful that this could be the solution to our problems.

I got my parts situated properly and switched on one of the preset vibration patterns. The Tenuto 2 delivers a 360 degree stimulation all over the penis and perineum with its 4 anatomically placed motors & 16 intensity levels. I felt a huge rush of blood through my body and my penis immediately stood at attention.

While I had ordered the Tenuto 2 to help with my ED, I was thrilled to see that my wife was enjoying its powerful vibrations on her just as much as I was – a very welcome side effect! MV.Health says that their products are designed for “your ultimate erection and your partner’s gratefulness,” so perhaps this shouldn’t have been a surprise, but I was so focused on my own issue that I didn’t consider that the Tenuto 2 would stimulate her so well and make our intimacy so much better.

I won’t go into much more detail here, but I’ll add that only after one session with the Tenuto 2, my skepticism was gone. I achieved and maintained a stronger erection than I had in years, and MV.Health’s promise of “earth-shattering orgasms” had come true.

Based on the fact that she was trying to catch her breath minutes later, I was confident that she was happy with my new purchase as well. Can this device cure ED?! Long story short, the Tenuto 2 has radically improved my relationship and has given me back the confidence that was lacking due to ED. As the reviewer before said, it’s “HEAVEN!”

For a limited time you can save up to 30% on the Tenuto 2 - Learn More Now!

Heading into my mid-40s, I began to notice changes in my sexual health. Erections became more challenging to achieve and sustain. Like many men my age, I suspected that stress, job pressures, and the demands of family life were taking their toll. I tried to ignore it for a bit and hoped that it would sort itself out (a guy can dream, right?), but as months passed and the situation worsened, I decided it was time to look for a solution.

My initial reluctance to visit a doctor led me to explore online options. I hoped to find an alternative to Viagra, that wouldn't come with side effects like headaches or prolonged erections. During my search, I stumbled upon MV.Health, a company known for its cutting-edge sexual wellness devices. After taking their online quiz, I was recommended the Molto, a device designed to enhance erections and promote prostate health by delivering targeted vibrations directly to the prostate.

I was skeptical… but also intrigued enough to keep researching. I delved deeper into the Molto, and became increasingly impressed by its credentials: it’s built with patented tech, FDA registered, and backed by a decade of research and rigorous clinical testing with numerous papers in the Journal of Sexual Medicine. Plus, it is endorsed by top doctors from Mayo Clinic, Cedars-Sinai and Rush. Reviews from other users were overwhelmingly positive, describing it as a game-changer. What’s more, it’s FSA/HSA eligible. Convinced, I decided to give it a try.

The Molto arrived quickly and discreetly, sparing me any embarrassment from nosy neighbors. I won’t lie, I was still a bit hesitant to try a prostate vibrator, even though the website promised that it was “designed for comfortable use.” I just wasn’t sure what to expect. But if Molto was able to enhance arousal and provide heightened sensations, leading to a better experience for me and my wife, I was willing to give it a shot.

Molto’s unique ultra-flexible and ultra-slim design replicates the sensation of an index finger and can comfortably reach and stimulate the prostate without requiring assistance. Molto’s vibrations can help relax the prostate to aid in the release of fluid build-up and improve prostate health, in a pleasurable and accessible manner.

It took a moment to get accustomed to the feel of it, but I was determined to give it an honest shot. That evening, my wife and I decided to test it out. She had always been supportive despite my struggles, and I was hopeful this could improve our intimate moments.

Once activated, the Molto’s vibrations, which can be activated on the device or via app, provided immediate stimulation. My initial skepticism vanished as I experienced a robust erection, something I hadn’t felt in a long time. The device's design ensures comprehensive stimulation and really enhanced sensations, intensifying the entire experience.

What surprised me most was the positive impact on my wife. While I focused on solving my ED, I hadn’t considered how much the Molto would enhance her pleasure as well. MV.Health's claim that their products benefit both partners proved true, making our intimate encounters more satisfying than ever.

In addition to its benefits for ED, I also noticed improvements in my overall prostate health. Regular use of the Molto helped me feel more confident about my sexual health, knowing that I was taking proactive steps to maintain it.

Long story short, the Molto exceeded my expectations. It restored my ability to maintain strong erections and significantly improved my confidence in the bedroom. The device’s benefits for prostate health are an added bonus. If you’re struggling with ED and looking for a reliable, side-effect-free solution, the MV.Health's Molto might just be what you need.

Save up to 35% on the Molto when you shop on MV.Health today!

Erectile dysfunction (ED) is way more common than most guys think. Over 30 million men in the U.S. deal with it. And while pills like Viagra work for some, they’re not a fit for everyone—whether it’s side effects, medical conditions, or just wanting something more natural.

That’s where Tenuto 2 comes in. It’s a clinically proven wearable medical device that uses vibration to offer a novel, non-pharmacological approach to managing ED—without meds, needles, or stress.

What Causes ED?

Not all ED is the same. Here are the most common types:

• Physical ED: Caused by health issues like diabetes, high blood pressure, or nerve damage. These affect blood flow and nerve signals to your penis.

• Mental ED: Anxiety, stress, or even overthinking it can kill the mood and block your erection.

• Combo ED: Both physical and mental causes—this is actually super common.

• Situational ED: Only happens sometimes (like with a new partner or under pressure).

Understanding the cause can help you find what works—and Tenuto 2 is built to support multiple types at once.

How Vibration Therapy Helps ED (Backed by Science)

Doctors have used vibratory stimulation in men’s health for years—and the results are impressive. Research indicates that targeted mechanical vibration can:

• Increase Blood Flow: Helps more blood reach your penis so you can get and stay hard.

• Activate Key Nerves: Especially the pelvic floor nerves that control erections and climax.

• Trigger Nitric Oxide: Localized vibration may enhance endothelial nitric oxide synthase (eNOS) activity—a key chemical that relaxes blood vessels to help you stay firm.

• Support Recovery: For men recovering from nerve damage due to pelvic surgery, vibration can help re-establish neural activity via preserved reflex arcs. Basically, it helps wake things up again.

How Tenuto 2 Works

Tenuto 2 is a flexible, wearable medical device made from medical-grade silicone. It’s FDA-registered and clinically proven to reduce ED by 2x—both in psychogenic ED and neurological ED. It wraps comfortably around the base of your penis and under your perineum (the area between your scrotum and anus). It has 4 powerful motors that send targeted vibrations to help you:

• Get harder, faster

• Stay erect longer

• Boost sensation and climax

• Feel more confident during sex

Bonus: It can also stimulate your partner during sex, so you’re both winning.

It’s waterproof, rechargeable, and you can control everything (patterns, speed, intensity) through an app or optional remote.

• Men with Contraindications to Oral Medications: Those with cardiovascular comorbidities or nitrate use may prefer or require a non-pharmacologic option.

• Postoperative Patients: Men recovering from radical prostatectomy or colorectal surgeries may benefit from neural reactivation and blood flow enhancement.

• Patients with Psychogenic ED: The device can help reduce anxiety-induced inhibition through tactile stimulation and performance confidence.

• Couples Seeking Enhanced Intimacy: Tenuto 2’s design allows for use during intercourse, encouraging partner involvement and reducing the stigma associated with ED treatment.

Who It’s Great For

Tenuto 2 can help if you:

• Can’t take ED pills: Those with cardiovascular comorbidities or nitrate use may prefer or require a non-pharmacologic option.

• Have medical issues: (like heart problems) and need a drug-free option.

• Are recovering from surgery: Men recovering from radical prostatectomy or colorectal surgeries may benefit from neural reactivation and blood flow enhancement.

• Have psychogenic ED: The device can help reduce anxiety-induced inhibition through tactile stimulation and performance confidence.

• Want to enhance intimacy with your partner: Tenuto 2’s design allows for use during intercourse, encouraging partner involvement and reducing the stigma associated with ED treatment.

Why Try It?

Tenuto 2 is clinically proven to improve ED by 2x. It’s easy to use, discreet, and made for real men who want real results—without side effects. Thousands of guys are already using it to get their performance and confidence back.

The Bottom Line

If ED is getting in your way, Tenuto 2 gives you a smarter, science-backed way to take control. No pills. No pressure. Just better, longer-lasting sex—and a partner who’s more than happy.

Talk to your doctor to see if it’s right for you. Then get ready to feel like yourself again.

If you’ve ever found yourself struggling with erectile dysfunction (ED) or performance anxiety, you’re not alone. These common issues can significantly impact relationships and self-confidence, but there’s now a clinically proven device designed to help.

MV.Health's Tenuto 2 is an FDA-registered male vibratory medical device that’s changing the game when it comes to erectile dysfunction. Unlike traditional methods, this wearable device offers a unique approach to improving erectile function and boosting confidence in the bedroom. What sets Tenuto 2 apart is its ability to benefit both partners simultaneously, creating a more connected and satisfying experience.

But how does the Tenuto 2 really revolutionize your intimate moments and bring a new level of confidence to your relationship?

The Tenuto 2

Tenuto 2 is a state-of-the-art, wearable male vibratory medical device designed to address ED and performance anxiety while enhancing intimacy for both partners. This ultra-flexible device fits comfortably at the base of the penis, featuring four powerful motors strategically placed to maximize stimulation.

Three motors positioned at the front of the device send medically optimized vibrations across the penis, while a fourth motor targets the perineum. This combination of vibrations increases blood flow and heightens sensation, which is crucial for achieving and maintaining erections. Simultaneously, the front motors provide stimulation to a partner’s vulva and clitoris, enhancing arousal and lubrication for a mutually satisfying experience.

Tenuto 2’s ingenious design goes beyond just helping you get erect. It also aids in maintaining firmer, longer-lasting erections by comfortably restricting blood flow to the penis. With 16 intensity levels and 8 pre-set vibration patterns, users can customize their experience to suit their preferences.

Key Benefits and Features

• Clinically proven to reduce ED by 2X

• FDA-registered and doctor-recommended

• One-time cost, FSA/HSA eligible

• No medications or side effects

• Ultra-flexible design fits various penis shapes and sizes

• Made with body-safe, medical-grade premium silicone

• 100% water-resistant for versatile use

Tenuto 2 offers an accessible alternative to ED prescription medications, especially beneficial for those with pre-existing conditions or those wishing to avoid the potential side effects of pills. Its effectiveness has been demonstrated in clinical studies, including one published in the Journal of Sexual Medicine showing improved erectile dysfunction in a post-surgical colorectal cancer patient.

Whether you’re looking to overcome occasional anxiety in the bedroom or seeking to enhance overall intimacy with your partner, Tenuto 2 provides a discreet and effective solution. By investing in this innovative device, you’re not just addressing physical concerns, you’re opening the door to renewed confidence and deeper connection in your relationship.

After 40, your prostate starts changing whether you’re aware of it or not. And while the symptoms may start off subtle—slower ejaculation, more night-time bathroom trips, or less sensation during sex—they’re anything but harmless.

The truth? If you’re over 40, your prostate needs attention. And not just from a doctor once things go wrong. With a little preventative care, you can avoid years of discomfort, frustration, and even serious conditions like chronic prostatitis or erectile dysfunction.

That’s where Molto comes in —an ultra-slim, flexible prostate medical device clinically proven to improve prostatitis symptoms by 57%. Designed by urologists and engineered for comfort, Molto delivers targeted stimulation to help reduce inflammation, relieve pressure, and improve performance.

Stop Prostate Pain Before It Stops You

Prostate Pain (Prostatitis) is one of the most common prostate issues men face. Age, stress, poor circulation, and a sedentary lifestyle all contribute. Left unchecked, it can become chronic—causing pelvic pain, painful urination, weaker ejaculations, and erectile problems.

But prostatitis doesn’t appear overnight; inflammation builds, circulation drops, pressure mounts. Early intervention is key.

• Molto’s targeted vibrations increase blood flow directly to the prostate, helping quell the inflammation that causes long-term damage.

• In clinical studies, symptoms improved by 57%—without drugs, surgery, or invasive treatments.

For men who want to stay ahead of their health, it’s the simplest solution you never knew you needed.

Improve Ejaculations

As you age, ejaculations can feel weaker, smaller, or even painful—often a prostate “distress signal.”

• Inflamed or blocked tissue interferes with the muscles that power ejaculation.

• Molto’s urologist-inspired, bent-and-slim profile reaches the gland precisely and comfortably.

• Regular, gentle massage reduces pressure, stimulates surrounding muscles, and clears blockages, leading to stronger, more satisfying finishes.

You’ll feel the difference during intimacy and after, too.

Don’t Let Restroom Anxiety Rule Your Life

Frequent urination, urgency, weak stream, night-time trips—classic signs of an enlarged or inflamed prostate. Swelling pinches the urethra, disrupting normal flow and wrecking sleep and confidence.

Molto eases that pressure from the inside. By reducing inflammation and restoring circulation, it helps re-establish a smooth, steady stream—all from the comfort of home.

Designed With Men (and Real Life) in Mind

Most men never picture a vibrating medical device as a health tool, but Molto was created to change that.

• First-of-its-kind, doctor-recommended design that looks approachable, not clinical.

• Ultra-slim shape makes insertion easy, even for beginners.

• Soft flexibility adapts to your anatomy.

• Quiet, powerful motors deliver a therapeutic massage that feels as good as it is for your health.

Whether you’re brand-new to prostate care or already seeing symptoms, Molto offers a safe, effective, non-pharmaceutical way to support your body—on your own terms.

Don’t Wait for a Wake-Up Call

Most men wait until pain forces action—but the earlier you care for your prostate, the better the outcome. Prevention, performance, or simply feeling like yourself again—Molto covers it all.

Think of it as a workout for your pelvic health that helps you stay stronger, last longer, and feel better doing it.

Take the guesswork out of prostate care and make Molto part of your routine, because waiting won’t make it better.

When you’re in the prime of your life, it’s easy to feel invincible on all fronts. Why bother prioritizing something like prostate health? After all, that’s an issue for aging folks, and you’re still at the top of your game. But what if we told you that being proactive about prostate health could be downright pleasurable? It is … when you have the right tool for the job.

For the best in enjoyable prevention, the doctor-designed prostate vibrating medical device Molto is a men’s health and wellness game-changer. Here are 6 unexpected ways this prostate device not only keeps you ahead in the health game but also elevates your performance in the bedroom.

1. Reduce the risk of prostate cancer

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime, making it the 2nd most common type of cancer (after skin cancer). While there are certain risk factors like genetics that you can’t control, you can be proactive about your prostate health with the help of Molto in a few unexpected ways.

A 2016 study found that men who ejaculated an average of 21 times per month had a lower risk of developing prostate cancer. It’s likely because ejaculation eliminates prostatic fluid build-up, keeping the prostate gland healthy and functioning.

Meanwhile, the prostate is a sensitive gland capable of providing immense sensations when stimulated. Molto offers a customizable way to find the pressure that works for you with targeted vibrations, 16 different intensity levels, and a catalogue of pre-programmed patterns. Its ultra-slim design makes it easy for beginners to explore the profound benefits of prostate massage.

2. Support Prostate Health with Targeted Stimulation

The prostate plays a key role in both reproductive function and intimate wellness. Stimulating this area can trigger a powerful full-body response, distinct from typical sensations experienced during arousal.

Molto is designed to target the prostate with precise, powerful vibrations—offering a new way for men to explore this often-overlooked area. Its sleek, flexible design supports comfortable use and allows users to find the optimal angle for targeted stimulation, whether on the prostate itself or around the highly sensitive nerve endings of the anus.

With a bendable neck, multiple vibration patterns, and 16 intensity levels, Molto delivers a fully customizable experience tailored to your body’s needs. It’s also beginner-friendly, ultra-slim, and built with intuitive one-handed controls—making it a smart, user-friendly tool for anyone looking to support their intimate health through guided exploration.

3. Prevent prostate inflammation and pressure

Prostatitis, AKA prostate inflammation, isn’t just uncomfortable—it can be a real pain that affects your prostate, pelvis, and groin. It can make sitting, standing, or daily life difficult.

One cause is a buildup of prostatic fluid. Traditional treatment? A urologist’s finger in your anus for manual massage. That’s why Molto was designed by urologists to be the width of a finger and mimic the movements of a doctor’s finger.

Using vibrations that massage the prostate’s tissues, Molto may help release and prevent the buildup of fluids that leads to inflammation. It’s an at-home preventive measure that offers a comfortable, private way to maintain prostate health.

4. Improve the intensity of your ejaculations

The prostate is responsible for producing semen, so a healthy prostate = powerful ejaculations.

Molto helps keep your ejaculations strong and satisfying. Its gentle, targeted vibrations and 16 different speeds can help remove fluid blockages and ease pressure. By stimulating the prostate, you can relieve inflammation and increase the intensity of your finish—or recover lost intensity due to prostate issues.

5. May boost blood flow for healthier prostate function

Proper blood flow is essential to optimal prostate health. It helps maintain tissue health and supports semen production.

What improves blood flow? Vibrations. Molto delivers direct vibration to the prostate, providing both a health boost and a buzzing good time. Its ultra-slim, flexible design reaches the targeted area with ease—right where you need it.

Think of Molto as a pump for your prostate—no gym required.

6. May keep your urination flow fluid

Trouble starting or completing urination? It could be a sign of prostate swelling, which can constrict the urethra and make a simple task into an awkward bathroom dance.

Stimulating vibrations to the prostate can help reduce swelling by clearing the prostatic duct—leading to a more fluid, confident flow.

And More …

Molto is designed to stimulate the P-spot with powerful, targeted vibrations, offering men a new way to explore these explosive experiences. Its sleek and user-friendly design makes exploring your P-spot more like playing your favorite game—exciting, rewarding, and with plenty of surprises along the way.

Thanks to its flexibility, Molto helps you discover the P-spot positions you prefer. Bend the device’s flexible and slim neck to position the motor exactly where you want it. Coupled with powerful vibrations, a slew of vibe patterns, and 16 different speeds, you get a fully customizable experience. Molto is beginner-friendly, ultra-slim, with one-hand usability and large, tactile buttons. Now this is a proactive pleasure design we can get behind!

When it comes to improving prostate health, it’s clear that Molto isn’t just another vibrating device—it’s a doctor-designed, preventative powerhouse packing a range of health benefits. From boosting blood flow to keeping your fluids flowing to powerful, satisfying finishes, Molto offers an experience that’s hard to pass up.

After all, who said preventative care couldn’t be pleasurable? Try this FSA/HSA Eligible prostate device today.

• Crafting effective prompts to guide Large Language Models (LLMs) toward accurate, useful outputs.

• It's iterative: experimenting, evaluating, and refining prompts is crucial.

Key Elements of Effective Prompt Engineering

1. LLM Output Configuration

Configure the model settings effectively:

• Output Length: More tokens = higher cost and latency.

• Temperature: Controls randomness.

  • Lower temperatures (0.0 - 0.3) → More deterministic and focused results.

  • Higher temperatures (>0.7) → More creative and varied outputs.

• Top-K: Limits sampling to the K highest-probability tokens.

• Top-P (nucleus sampling): Samples from top tokens until cumulative probability P is reached.

Recommended default configurations:

• Balanced results: Temperature 0.2, top-P 0.95, top-K 30.

• More creative: Temperature 0.9, top-P 0.99, top-K 40.

• Deterministic results: Temperature 0.0 (useful for math problems).

2. Prompting Techniques

Zero-shot Prompting

• Provide simple instructions without examples.

• Good for straightforward tasks.

One-shot & Few-shot Prompting

• Include one or more examples within the prompt.

• Enhances accuracy and consistency, particularly useful for complex or structured tasks.

System, Contextual, and Role Prompting

• System prompting: Defines the overall task context and constraints (e.g., format outputs as JSON).

• Contextual prompting: Offers additional context for precise results.

• Role prompting: Assigns the model a persona or role (teacher, comedian, travel guide, etc.), shaping its tone and content.

Step-back Prompting

• Start broadly, then narrow down specifics to enhance contextual accuracy.

• Helps models reason effectively.

Chain of Thought (CoT) Prompting

• Encourages LLMs to explain reasoning steps explicitly (e.g., math problems).

• Significantly improves accuracy and interpretability.

Self-consistency

• Run the same prompt multiple times at higher temperatures, then choose the most common response.

• Good for reasoning and classification tasks.

Tree of Thoughts (ToT)

• Extends CoT by simultaneously exploring multiple reasoning paths.

• Effective for complex tasks needing deep exploration.

ReAct (Reason & Act)

• Combines reasoning with external tool usage (like search engines) for better problem-solving.

• Useful for factual queries requiring external validation or data.

3. Automatic Prompt Engineering

• Automating prompt creation by prompting an LLM to generate multiple potential prompts.

• Evaluate and select the best-performing prompt using metrics like BLEU or ROUGE scores.

4. Code Prompting Techniques

• LLMs can write, explain, translate, debug, and review code.

• Clearly instruct models on desired programming languages and outcomes.

• Test and verify the generated code for correctness.

5. Multimodal Prompting

• Involves using multiple formats (text, images, audio) in prompts.

• Enhances clarity and context (dependent on model capabilities).

Best Practices for Prompt Engineering

General Tips

• Provide clear, concise instructions.

• Include relevant examples: One-shot or few-shot examples dramatically improve performance.

• Design simple prompts: Avoid overly complex language or irrelevant information.

• Be specific about outputs: Clearly state expected results (structure, format, content).

• Favor positive instructions over negative constraints.

Controlling Output

• Explicitly instruct output length or style when necessary (e.g., "Explain quantum physics in a tweet-length message").

Variables in Prompts

• Use dynamic variables to easily adapt prompts (e.g., {city} → "Amsterdam").

Input and Output Formats

• JSON is recommended for structured outputs to minimize hallucinations and increase reliability.

• JSON Schemas can help structure inputs, defining clear expectations for LLMs.

Iterative Development

• Continuously test, refine, and document prompts.

• Record prompt versions, configurations, model outputs, and feedback for reference and improvement.

Chain of Thought Specific Tips

• Always put the reasoning steps before the final answer.

• Set temperature to 0 for reasoning-based tasks to ensure deterministic responses.

Prompt Documentation

Use this structured format to document prompt attempts for easy management and future reference:

FieldDetails to includeNamePrompt name/versionGoalSingle-sentence description of the prompt’s purposeModelModel name/versionTemperatureValue (0.0 - 1.0)Token LimitNumeric limitTop-KNumeric settingTop-PNumeric settingPromptFull text of the promptOutputGenerated output(s)

Biological and Hormonal Changes During Menopause

Menopause marks the end of a woman's reproductive years, typically occurring between ages 46 and 55. This transition happens as the ovaries gradually stop releasing eggs and reduce the production of estrogen and progesterone. The period leading up to menopause, known as perimenopause, is characterized by hormonal fluctuations and irregular menstrual cycles.

During perimenopause, cycles can become erratic, leading to symptoms like hot flashes, mood swings, and sleep disturbances. Once menopause is reached—defined as having no periods for 12 consecutive months—the ovaries produce very little estrogen and progesterone, causing significant physical and emotional changes.

Common Physical Symptoms of Menopause

Menopause commonly brings several physical symptoms:

• Hot Flashes and Night Sweats: Sudden feelings of heat, often with sweating and flushing, due to changes in the brain's temperature regulation.

• Sleep Disturbances: Difficulty sleeping, often related to night sweats.

• Vaginal Dryness: Thinning and drying of vaginal tissues, causing discomfort and pain during sex.

• Urinary Changes: Increased frequency and urgency, possibly more infections.

• Joint and Muscle Pain: Increased stiffness or aches.

• Weight and Metabolic Changes: Increased belly fat and weight gain.

• Skin and Hair Changes: Drier skin, thinning hair.

Psychological Impacts of Menopause

Menopause can also influence emotional well-being:

• Mood Swings and Irritability: Emotional fluctuations due to hormonal shifts.

• Anxiety and Depression: Increased feelings of anxiety, worry, or depression, influenced by hormonal changes and life stressors.

• Memory and Concentration Issues (Brain Fog): Difficulty concentrating or remembering due to hormonal fluctuations, typically temporary.

Hormone Replacement Therapy (HRT)

Hormone Replacement Therapy involves supplementing estrogen or estrogen plus progesterone to relieve menopausal symptoms:

• Benefits: Effective relief of hot flashes, night sweats, vaginal dryness, and protection against bone loss (osteoporosis).

• Risks: Slight increase in risks such as breast cancer, blood clots, and stroke, depending on the individual's health history and timing of treatment.

• Current Approach: Personalized treatment plans aiming for the lowest effective dose, typically started within 10 years of menopause onset.

Non-Hormonal Treatment Options

For women who prefer or need alternatives to hormones, several non-hormonal treatments are available:

• Medications: Low-dose antidepressants (SSRIs/SNRIs), gabapentin, clonidine, oxybutynin, and fezolinetant can help reduce hot flashes.

• Vaginal Treatments: Non-hormonal lubricants and moisturizers, and medications like ospemifene or DHEA vaginal inserts.

• Lifestyle Adjustments: Stress reduction techniques, exercise, acupuncture, cognitive-behavioral therapy, dietary adjustments, and weight management.

Menopause and Cardiovascular Health

Menopause accelerates cardiovascular risk due to hormonal changes, contributing to increased blood pressure, cholesterol changes, and abdominal fat. Women should prioritize a heart-healthy lifestyle:

• Balanced diet (rich in fruits, vegetables, whole grains, and lean proteins)

• Regular exercise

• Avoiding smoking and limiting alcohol

• Regular cardiovascular screenings

Bone Health and Osteoporosis Risk

Postmenopausal estrogen decline leads to accelerated bone loss, increasing the risk of osteoporosis and fractures. Strategies for protecting bone health include:

• Adequate calcium and vitamin D intake

• Regular weight-bearing and strength exercises

• Lifestyle modifications like quitting smoking and moderating alcohol intake

• Fall prevention strategies

• Bone density screenings and appropriate medical treatments (e.g., bisphosphonates, hormone therapy, or other medications)

Menopause and Cognitive Function

Menopause-related hormonal changes can cause temporary cognitive symptoms such as forgetfulness and difficulty concentrating ("brain fog"). While these changes usually resolve post-menopause, maintaining brain health involves:

• Adequate sleep

• Regular physical exercise

• Mental stimulation (puzzles, learning new skills)

• Stress management (meditation, yoga)

• Balanced nutrition, particularly brain-healthy diets (e.g., Mediterranean diet)

Sexual Health and Intimacy

Menopause can significantly impact sexual health and intimacy through vaginal dryness, decreased libido, and changes in arousal or orgasm. To maintain a healthy and satisfying sexual life:

• Use lubricants and moisturizers regularly

• Consider vaginal estrogen or other therapies if suitable

• Communicate openly with partners about sexual needs and comfort

• Consider medical treatments like testosterone therapy or counseling for persistent low libido

• Maintain emotional intimacy through non-penetrative activities and nurturing relationships

Embracing the Transition

Menopause is a natural stage of life that can bring both challenges and opportunities. With awareness, proactive health management, and support, women can navigate menopause comfortably and confidently, maintaining vibrant health and meaningful relationships through midlife and beyond.

1958: Parker Montgomery founds Cooper Laboratories in California, marking the early roots of what will eventually become CooperSurgical. Over the following decades, Montgomery pursues aggressive acquisitions to build a healthcare conglomerate.

Early 1980s: Cooper Laboratories becomes overextended financially due to rapid expansion.

Late 1980s: Parker Montgomery is ousted from Cooper Laboratories following divestitures.

1990: CooperSurgical is officially formed as a distinct business unit of The Cooper Companies. CooperSurgical acquires Frigitronics, a Connecticut-based maker of cryosurgery devices for gynaecology, providing immediate entry into the women's healthcare market.

1991: Thomas Bender joins The Cooper Companies as chief operating officer and begins a turnaround strategy, focusing the company on medical devices. CooperSurgical purchases Euro-Med, a direct-mail order business supplying gynaecology instruments to physicians, expanding its reach and product offering.

1992: CooperSurgical introduces its own line of electrosurgical instruments and disposable loops for LEEP (Loop Electrosurgical Excision Procedure), enabling in-office diagnosis and treatment of precancerous cervical lesions.

1994: Thomas Bender becomes CEO of The Cooper Companies, continuing the focus on core medical device businesses, including CooperSurgical.

1996: CooperSurgical acquires Unimar, Inc., a company with disposable gynaecologic diagnostic products, broadening its range of essential everyday tools for OB/GYN practices.

1997: CooperSurgical acquires Marlow Surgical Technologies, gaining exclusive US distribution of an embryo transfer catheter, the Wallace®, marking its entry into the fertility field.

1998: CooperSurgical introduces Cerveillance, a digital imaging system for gynaecologists to document and track cervical examinations.

1999: CooperSurgical purchases the women's healthcare assets of BEI Medical Systems, Inc., including technologies for endometrial ablation and operative hysteroscopy, expanding its therapeutic offerings for uterine health.

2004: CooperSurgical acquires Milex Products, Inc., a manufacturer of disposable and consumable OB/GYN products like pessaries and diaphragms, significantly expanding its consumables portfolio and expecting to surpass $100 million in revenue.

November 2005: CooperSurgical acquires Inlet Medical, Inc., specialising in laparoscopic surgery devices, including trocar closure systems and kits for pelvic floor disorders.

November 2005: CooperSurgical also acquires NeoSurg Technologies, Inc., which developed a patented reusable/disposable trocar system for laparoscopic access.

2006: CooperSurgical acquires Lone Star Medical Products, Inc., known for its Lone Star® retractor system used in various surgical procedures, including OB/GYN.

2010: CooperSurgical acquires Summit Doppler Systems, a company that made fetal Doppler monitors and vascular Doppler systems, entering the prenatal care diagnostics market.

2012: The Cooper Companies completes the acquisition of Origio A/S, a leading global IVF medical device and media company based in Denmark, marking CooperSurgical's significant entry into the fertility market with a comprehensive range of IVF consumables.

August 2015: CooperSurgical acquires Reprogenetics, the largest laboratory specialising in preimplantation genetic screening (PGS) and diagnosis (PGD) for IVF, positioning itself at the forefront of fertility genomics.

December 2015: CooperSurgical acquires Research Instruments Ltd. (RI), a UK-based manufacturer of advanced IVF equipment, including micromanipulation devices and the RI Witness electronic witnessing system. The deal closes in early 2016.

April 2016: CooperSurgical acquires the assets of Recombine, Inc., a genetics company providing expanded carrier screening for prospective parents, further strengthening its genomic offerings.

May 2016: CooperSurgical acquires K-Systems (Kivex Biotec), a Danish company that pioneered IVF equipment such as bench-top incubators and laminar flow workstations, enabling CooperSurgical to outfit entire IVF laboratories.

Late 2016: CooperSurgical acquires the Wallace® line of IVF catheters and needles from Smiths Medical, bringing the well-regarded embryo transfer products back under its umbrella. The purchase is announced in November 2016.

2017: CooperSurgical acquires ParaGard®, the copper intrauterine contraceptive, from Teva Pharmaceutical for $1.1 billion, significantly expanding its contraception portfolio.

April 2018: CooperSurgical acquires The LifeGlobal Group, another major provider of IVF culture media and lab supplies, further expanding its offerings for embryology laboratories.

May 2018: Albert G. White III becomes CEO of The Cooper Companies.

2019: CooperSurgical acquires AEGEA Medical, adding the Mara® water vapor ablation system for heavy menstrual bleeding to its gynaecological therapeutic options.

July 2020: Holly Sheffield is appointed President of CooperSurgical.

Early 2021: CooperSurgical acquires Safe Obstetric Systems, a UK-based firm known for the Fetal Pillow® device used to ease difficult deliveries during C-sections.

2021: CooperSurgical launches ParaGard with a new single-handed inserter, simplifying the placement process for clinicians.

Early 2021: CooperSurgical acquires Embryo Options®, a digital platform for cryogenic storage billing and consent in fertility clinics.

2021: CooperSurgical acquires Generate Life Sciences, expanding its offerings in fertility and genetic services, including cord blood banking and donor egg services.

2022: CooperSurgical acquires products from Cook Medical’s Reproductive Health business, including the Bakri® Postpartum Balloon for managing postpartum haemorrhage and cervical cerclage devices.

2022: CooperSurgical introduces an improved IUD removal hook designed to snare hard-to-grasp fragments, addressing a clinician need.

Mid-2020s (Ongoing): CooperSurgical continues to focus on innovation, integration of digital health solutions, global expansion, and leveraging advanced technologies like genomics and artificial intelligence to further improve women's health and fertility outcomes. The company emphasises supporting women throughout their life cycle and accelerating what's possible in healthcare delivery.

2014

• Company Formation in the UK: MVHealth is established in the United Kingdom.

• Crescendo Prototype: Development of the initial prototype for the Crescendo device.

2015

• End-to-End R&D Centre Setup in UK: MVHealth establishes its own research and development facility in the UK.

• Tenuto Prototype: Development of the initial prototype for the Tenuto device.

• Seed Funding Round: MVHealth raises $1.3m with a pre-money valuation (PMV) of $4.9m.

2016

• Crescendo Launch: The Crescendo device is officially launched.

• Seed Funding Round: MVHealth raises an additional $718k with a PMV of $6.6m.

2017

• Apple iOS App Launch: MVHealth releases its companion application for Apple devices.

• Google Android App Launch: The Android version of the MVHealth application is launched.

• Poco Prototype: Development begins for the Poco device.

• Remote Prototype: Initial development of a remote control device (likely for their products).

• TC Disrupt, Pioneers: MVHealth participates in the TechCrunch Disrupt event.

• Hardware Club: MVHealth joins the Hardware Club, an exclusive community for hardware startups.

• Awards: MVHealth receives Red Dot Design and Virgin Voom Export awards, and is recognized as a Top 100 Startup.

2018

• Poco Launch: The Poco device is officially released.

• Remote Launch: The remote control device is launched.

• Fully-Owned Subsidiary in US: MVHealth establishes a subsidiary in the United States.

• Angels Funding Round: MVHealth secures $1.5m in funding with a PMV of $14.1m.

• FDA Class II Device Registration: MVHealth achieves FDA Class II medical device registration.

• Launched D2C Site: MVHealth begins selling directly to consumers through their own website.

• London Mayor's Programme: MVHealth participates in a program supported by the Mayor of London.

• Crescendo GPPPD & Tenuto ED Studies Published: Clinical studies demonstrating the effectiveness of Crescendo for Genito-Pelvic Pain Disorders (GPPPD) and Tenuto for Erectile Dysfunction (ED) are published.

• Awards: MVHealth receives Management Today, The Drum, Creative Tech, and Clio awards.

2019

• Tenuto 2 & Crescendo 2 Prototypes: Development of the next generation devices, Tenuto 2 and Crescendo 2, begins.

• Angels Funding Round: MVHealth raises a further $2m with a PMV of $18.9m.

• Whitelisted by Meta, Google, Microsoft: MVHealth achieves whitelisting status with major technology platforms.

• Upgraded to Sustainable Packaging: The company transitions to more environmentally friendly packaging.

• Developed Back Pain Belt for PainCareLabs & Compact Massager for Large Corporate: MVHealth leverages its technology to create products for other companies, including a back pain belt using their malleable technology for Pain Care Labs and a compact massager for an unnamed large corporate.

• Awards: MVHealth is recognized by Design Week (beating Apple), Veuve Clicquot, and IF Design Awards.

2020

• Tenuto 2 & Crescendo 2 Launch: The Tenuto 2 and Crescendo 2 devices are officially released.

• 1M+ App Downloads: The MVHealth companion application reaches over one million downloads.

• Awards: MVHealth receives Virgin Startups, Euro Product Design, LUXLife, Disruption50, Great British Entrepreneur, Welp, and The Escape100 awards.

2021

• Tenuto Mini, Legato, Molto Launch: MVHealth significantly expands its product line with the launch of Tenuto Mini, Legato, and Molto devices.

• Series A Funding Round: MVHealth secures $9.6m in Series A funding with a PMV of $36m.

• Awards: MVHealth is recognized as a Top 10 Deeptech company and a Top Product Design Company in the UK.

2022

• FSA/HSA Eligible: MVHealth devices become eligible for Flexible Spending Account (FSA) and Health Savings Account (HSA) spending.

• Crescendo FSAD Study Published: A clinical study demonstrating the effectiveness of Crescendo for Female Sexual Arousal Disorder (FSAD) is published.

• Endorsed by Mayo Clinic: MVHealth receives an endorsement from the Mayo Clinic.

• Member of CHPA & Advamed: MVHealth becomes a member of the Consumer Healthcare Products Association (CHPA) and AdvaMed (Advanced Medical Technology Association).

• Awards: MVHealth receives Dezeen, UX Design, World Future, Muse Design, and Good Design awards.

2023

• Firmo & Sotto Prototypes: Development begins for the Firmo and Sotto devices, targeting menopause symptoms and period pain/mastitis respectively.

• Legato FSAD and Tenuto Mini ED Studies Published: Clinical studies are published supporting the use of Legato for FSAD and Tenuto Mini for ED.

• Awards: MVHealth receives Bold IV, Impact Fifty, Titan, London Design, and DNA Paris Design awards.

2024 (Upcoming)

• Further development and potential launch of Firmo and Sotto devices.

• Continued focus on research, development, and market expansion.

• Pursuing full CMS reimbursement.

Ongoing Throughout the Decade:

• Research, Development & Manufacturing: Continuous efforts in new product development and updates to existing products.

• Regulatory & Compliance Approval: Obtaining necessary approvals such as FDA and CE for their devices.

• Clinical Trials & Paper Publications: Conducting clinical studies and publishing findings in peer-reviewed journals.

• Key Opinion Leader Onboarding & Endorsement: Building relationships with and securing endorsements from leading clinicians.

• User Feedback & Efficacy Establishment: Gathering user feedback and establishing the efficacy of their devices.

• Brand Awareness & Market Presence: Increasing brand recognition and expanding their presence in the market through direct sales, clinics, and hospitals.

• IP Portfolio Development: Continuously expanding their patent and trademark portfolio.

• Brand Credibility Building: Establishing trust through high efficacy, KOL endorsements, and user satisfaction.

• Large-scale Nationwide Marketing & Trade Exhibitions: Engaging in significant marketing efforts and participating in industry events.

• Reimbursement Efforts: Actively working towards securing reimbursement for their devices.

• Building Strategic Partnerships: Collaborating with large corporates and healthcare companies.

1910: A.L. Mills opens Northwestern Garment Factory in Chicago, manufacturing heavy-duty aprons for stockyard butchers.

1912: A.L. Mills shifts the business focus to medical workers, transforming it into Mills Hospital Supply and producing nurses' uniforms and surgical gowns for local hospitals.

Early Years (Post-1912): Mills Hospital Supply gains a reputation for quality and reliability within Chicago's medical community.

Around 1920s-1950s: Irving Mills, A.L.'s son, joins the business at age 12, takes over at 18, and expands Mills Hospital Supply beyond uniforms to a broader range of medical supplies. He pioneers creative distribution solutions like consignment shipping to remote areas. The company expands regionally with branch offices in Houston, Norfolk, and Columbus.

1961: Irving Mills sells Mills Hospital Supply to Cenco Scientific.

1966: Irving Mills' sons, Jim and Jon Mills, found Medline Industries, Inc. in Evanston, Illinois, with Irving's guidance. Jim becomes CEO and Jon becomes President.

1967: Medline earns approximately $1 million in revenue in its first year, primarily as a distributor.

1968: Medline opens its first manufacturing facility, a textile plant in Covington, Indiana, to produce gauze, gowns, and bed linens.

1972: Medline expands beyond textiles by acquiring an injection-moulding company, renamed Dynacor, to manufacture plastic medical goods. Medline goes public on the stock market.

1977: The Mills family buys back all public shares, and Medline becomes a private company again.

Late 1970s: Medline develops a reputation for offering quality products at lower prices, facing some scepticism about the quality of inexpensive goods.

1979: Medline launches a glossy, unconventional product catalogue resembling a fashion magazine, significantly boosting textile sales.

1984: Medline becomes the second-largest medical supply distributor in the US, with approximately $120 million in annual sales. The company opens a large headquarters, manufacturing plant, and distribution centre in Mundelein, Illinois.

1980s: The healthcare landscape shifts with the emergence of AIDS and increased focus on infection control and waste reduction, driving demand for disposable medical products.

January 1990: Medline launches a dedicated Sterile Procedure Tray (SPT) division to supply pre-packaged sterile kits.

Early 1990s: Medline operates four manufacturing plants across the US and an assembly facility in Mexico, along with 14 distribution centres. The consignment shipping program evolves into a formal program called ACCESS.

1993: Medline secures a five-year agreement to supply the U.S. Veterans Affairs (VA) hospitals nationwide.

1996: A former vice president alleges Medline violated the federal False Claims Act regarding the sourcing and quality of products supplied to the VA.

1997: Medline settles the False Claims Act case for $6.4 million without admitting wrongdoing. Jim and Jon Mills hand over day-to-day leadership to their sons, Charlie Mills (CEO) and Andy Mills (President), with Jim Abrams (COO).

Late 1990s: Medline becomes the largest privately held medical supply manufacturer in America. Healthcare providers face pressure to cut costs, leading Medline to focus on value-driven products and services. Medline partners with Neoforma.com, an online marketplace.

1999: Medline purchases the exam glove division of Kendall Healthcare (Tyco International).

Around 2000: Medline products increasingly originate from customer feedback, leading to innovations like advanced wound dressings (e.g., silver-infused bandages).

2000: Medline breaks ground on a new corporate headquarters in Northfield, Illinois, and acquires additional manufacturing space in Alabama.

September 11, 2001: The terrorist attacks lead to a surge in demand for personal protective equipment, with Medline's glove sales spiking.

End of 2001: Medline's annual sales reach $1.2 billion. The company secures a major contract to supply Ascension Health.

2007: Medline acquires the CURAD® first-aid brand, entering the retail market and selling to drugstores and supermarkets.

2009: Medline launches the Pink Glove Dance campaign for breast cancer awareness, which goes viral.

2011: Medline introduces the BioMask, the first FDA-cleared antiviral face mask in the U.S., under the Curad brand. Medline formally establishes Medline Europe, headquartered in the Netherlands.

2010s: Medline accelerates its international expansion, establishing operations in Europe, Asia, and the Pacific.

By 2014: Medline has a major European distribution hub in Kleve, Germany, which begins a significant expansion.

2018: Medline acquires Asid Bonz, a German medical supply firm. Medline launches a $1.5 billion Healthcare Resilience Initiative to strengthen its supply chain.

2020: Medline reports over $17 billion in annual revenue and is the largest private medical supply firm in the U.S. The COVID-19 pandemic puts unprecedented strain on global supply chains, including Medline's, despite its efforts to stockpile inventory.

Mid-2021: Medline has opened five new large distribution centres and increased on-hand inventory significantly as part of its resilience strategy.

June 2021: Medline announces a majority investment from private equity firms Blackstone, Carlyle, and Hellman & Friedman, valuing the company at around $34 billion. The Mills family retains a significant share and leadership remains in place.

End of 2022: Medline has over 50 distribution centres in North America (including a flagship facility in Grayslake, IL) and more than 20 manufacturing plants on the continent.

2023: Charlie Mills, Andy Mills, and Jim Abrams retire from their executive management roles and move to the Board of Directors. Jim Boyle becomes CEO and Jim Pigott becomes President/COO.

2024: Medline's supply chain is recognised as "Best in Business" for reliability and innovation. Medline continues to invest in technology and expands its product offerings, reaching over 125 countries.

1970s: Humble Origins in Ohio

• 1971: Robert D. Walter, aged 26, purchases the struggling Ohio food wholesaler Monarch Foods with a small group of investors for $135,000 cash and assumption of $1.3 million in debt.

• Early 1970s: Walter renames the company Cardinal Foods, after Ohio's state bird. He focuses on turning the "also-ran" grocery distributor into a regional force.

• Late 1970s: The food distribution industry undergoes rapid consolidation, putting pressure on smaller firms like Cardinal. Walter's diversification attempts, including a supermarket chain, have mixed success, and a salmonella outbreak creates further challenges.

• 1979: Sensing opportunity in the booming pharmaceutical trade, Cardinal Foods makes a pivotal shift by purchasing the Bailey Drug Company, a small drug distributor in Zanesville, Ohio, for $4.4 million. This marks Cardinal's decisive entry into pharmaceutical wholesaling.

• 1979: The name Cardinal Health is effectively born as the company shifts its focus entirely to healthcare, though the official adoption of the name would take a few more years.

1980s: Building a National Distribution Network

• Early 1980s: Walter fully divests the old grocery operations to focus exclusively on healthcare.

• 1983: Robert D. Walter buys out his original investors and takes Cardinal Health public.

• 1980s: Cardinal Health embarks on a period of significant growth, acquiring regional drug wholesalers across the United States to build a national distribution network.

• Mid-1980s: Cardinal Health embraces emerging computer technology, developing its own internal software for inventory, order, and delivery management, leading to increased efficiency and faster shipping times.

• Late 1980s: Cardinal Health continues its acquisition strategy, expanding its reach into the Southeast and Mid-Atlantic regions.

• 1988: Cardinal Health divests its original food distribution business entirely, signifying its complete commitment to the healthcare sector.

1990s: Expansion and Diversification

• Early 1990s: Cardinal Health is poised to become a top-tier U.S. healthcare company, continuing its acquisition-led growth strategy.

• 1991: Cardinal Health's annual sales reach $1 billion.

• 1994: Cardinal Health merges with Whitmire Distribution, a major wholesaler based in Texas, propelling Cardinal into the third national spot in the drug distribution industry and providing a significant foothold in the Western U.S.

• 1995: Cardinal Health diversifies beyond pure drug distribution with the acquisition of Medicine Shoppe International, the largest franchisor of independent retail pharmacies in the U.S., marking its first significant venture outside of wholesale distribution.

• 1996: Cardinal Health further diversifies into medical technology with the acquisition of Pyxis Corporation, a specialist in automated dispensing cabinets for hospitals, for $867 million.

• 1997: Cardinal Health acquires Owen Healthcare, a leading provider of pharmacy management services for hospitals, further integrating itself into healthcare provider operations.

• February 1999: Cardinal Health makes a transformative acquisition of Allegiance Healthcare, a medical-products manufacturer and distributor spun off from Baxter International, for $5.4 billion. This establishes Cardinal's Medical segment alongside its Pharmaceutical segment.

• 1999: Cardinal Health's annual revenues skyrocket to $21 billion, making it one of the fastest-growing companies in America. By the end of the decade, it is ranked among the largest companies in the U.S.

2000s: New Millennium, New Challenges

• 2000: Cardinal Health enters the new millennium with record sales of over $25 billion annually and operations spanning five continents and 22 countries. It launches corporate and e-commerce websites.

• 2001: Cardinal Health employs nearly 50,000 people worldwide. It acquires Bindley Western Industries, a large pharmaceutical distributor, further consolidating its lead in drug wholesaling.

• Early 2000s: Cardinal Health expands into specialty pharmaceuticals and nuclear pharmacy.

• 2002 (Implied): Cardinal Health acquires Syncor, becoming the operator of the nation's largest chain of radiopharmacies.

• 2006: After 35 years, founder Robert D. Walter prepares to step back from day-to-day management, inviting R. Kerry Clark to become CEO while Walter remains Chairman.

• 2008: Both R. Kerry Clark and Robert D. Walter retire, marking the end of Cardinal's founding era. George S. Barrett takes over as Chairman and CEO in September. Cardinal faces scrutiny from the DEA regarding suspicious opioid orders.

• 2009: George S. Barrett leads the spin-off of Cardinal's clinical and medical products segment into a new company called CareFusion, which includes Pyxis dispensing systems and other medical technology. Cardinal Health retains its core pharmaceutical distribution and medical consumables business. Cardinal launches its Outpatient Care division.

• 2008-2009: The Great Recession tests the resilience of the healthcare supply chain, but Cardinal's services remain in steady demand.

• By 2010: Cardinal Health has a sharper focus on its Pharmaceutical and Medical segments and is one of the "big three" drug distributors in America.

2010s: Extending Reach – Specialty, Home, and Global Expansions

• 2010: Cardinal Health acquires Healthcare Solutions Holding, forming the basis of its Specialty Solutions division, and Kinray, a large independent drug distributor serving the New York area. It also acquires a majority stake in Yong Yu, a leading Chinese drug distributor.

• 2013: Cardinal Health forms Red Oak Sourcing, a joint venture with CVS Caremark, to become the largest generic drug sourcing entity in the U.S. It also acquires AssuraMed, a leading direct-to-home medical supplies distributor, for $2.07 billion, rebranding it as Cardinal Health at-Home Solutions.

• 2014: Red Oak Sourcing begins operations.

• Mid-2010s: Cardinal Health China serves thousands of hospitals and pharmacies.

• 2015: Cardinal Health acquires Cordis, a cardiology and endovascular device manufacturer, from Johnson & Johnson for approximately $1.94 billion.

• 2016: Cardinal Health pays $44 million to settle allegations by the DEA regarding failure to report suspicious opioid orders.

• 2017: Cardinal Health sells its China business to Shanghai Pharma for $1.2 billion. It also agrees to acquire a suite of medical products from Medtronic for $6.1 billion, which closes in July 2017, roughly doubling the size of Cardinal's Medical segment.

• 2018: Mike Kaufmann takes over as CEO from George Barrett.

• 2018-2019: Dozens of lawsuits are filed against Cardinal Health and other distributors regarding their role in the opioid crisis.

• 2019: Cardinal Health opens the Fuse innovation center, focused on developing digital healthcare solutions.

2020: Frontline Support in a Global Pandemic

• Early 2020: Demand for PPE surges due to the COVID-19 pandemic. Cardinal Health's Medical segment works to secure and distribute supplies.

• March 2020: CEO Mike Kaufmann participates in a White House briefing, highlighting public-private coordination to address supply needs.

• April 2021 (Retrospective): Cardinal Health is awarded a federal contract to manage a segment of the Strategic National Stockpile.

• 2020: Cardinal Health plays a significant role in distributing COVID-19 related medications and, later, vaccines. A recall of some Cardinal Health-branded surgical gowns occurs due to manufacturing issues.

Mid-2010s to Present: Innovation, Acquisition and Adversity (Continued)

• July 2021: Cardinal Health, along with other distributors and Johnson & Johnson, agrees to a landmark $26 billion settlement to resolve most opioid lawsuits, with Cardinal's share being $6.4 billion to be paid over 18 years.

• 2021: Cardinal Health sells Cordis to a private equity firm.

• 2022: Jason Hollar becomes CEO of Cardinal Health, succeeding Mike Kaufmann. Cardinal Health acquires ScalaMed, a smart prescription management app.

• 2023: Cardinal Health announces a partnership with Zipline to trial long-range drone delivery of medical supplies in North Carolina.

• Ongoing 2020s: Cardinal Health focuses on digital health, data analytics, AI, and innovations like drone delivery. It navigates the evolving healthcare landscape, including the rise of home-based care and personalised medicine. The company emphasises its role as a healthcare partner, providing solutions beyond just product distribution.

Cast of Characters

1840s:

• 1844: Werner von Siemens experiments with medical applications of electricity, relieving his brother's toothache with a self-built induction device.

• October 1847: Werner von Siemens and Johann Georg Halske found Siemens & Halske (S&H) in Berlin, initially focused on telegraph technology.

• Late 1847: Siemens & Halske introduces its first medical product, the Slide Inductor, an electrotherapy machine.

1870s - 1890s:

• 1877: Erwin Moritz Reiniger opens a workshop for electro-medical devices in Erlangen.

• 1886: Reiniger partners with Max Gebbert and Karl Schall to found Reiniger, Gebbert & Schall (RGS), a leading producer of medical instruments, particularly for X-ray technology.

• November 1895: Wilhelm Conrad Röntgen discovers X-rays.

• Late 1895: Siemens engineers begin designing the company's first X-ray tubes for medical use within weeks of Röntgen's discovery.

• 1896: Siemens produces the first industrially manufactured X-ray tubes for medical diagnostics.

• 1901: Friedrich Dessauer establishes a lab in Aschaffenburg, which becomes Veifa-Werke, dedicated to exploring X-rays.

1900s - 1930s:

• Early 20th Century: Siemens & Halske, RGS, and Veifa-Werke compete and collaborate in the emerging field of radiography.

• 1914 - 1918: World War I causes significant challenges for the companies, with market collapse, worker conscription, and a shift towards military production. Veifa-Werke falls into financial trouble.

• Post-WWI: Germany experiences hyperinflation and instability. RGS accumulates heavy debts by 1924.

• January 1, 1925: Siemens & Halske takes over Reiniger, Gebbert & Schall (RGS) to provide financial stability. RGS initially remains an independent subsidiary.

• 1932: The merger of Siemens & Halske and RGS is structurally completed with the formation of Siemens-Reiniger-Werke (SRW) as a unified medical technology company within Siemens. Headquarters and manufacturing are consolidated in Erlangen.

• 1933: Siemens introduces the world's first rotating anode X-ray tube, marketed as "Pantix," significantly improving X-ray performance.

• 1933: The National Socialists come to power in Germany.

• 1939 - 1945: World War II disrupts production at SRW, with employees conscripted and some facilities employing forced labour.

1940s - 1960s:

• Post-1945: Siemens-Reiniger-Werke rebuilds and re-establishes international connections.

• 1950: SRW reintroduces itself on the world stage at the International Congress of Radiology in London.

• Early 1950s: Inge Edler and Carl Hellmuth Hertz in Sweden, with Siemens support, achieve the world's first echocardiogram using ultrasound.

• 1958: A team at Siemens-Elema in Sweden designs the first implantable cardiac pacemaker, which is implanted in a patient by Åke Senning in Stockholm.

• Mid-1960s: Siemens engineer Ralph Soldner invents the Vidoson, the world's first "real-time" ultrasound machine.

• 1966: Siemens AG is formed, and the medical technology division becomes known internally as "Wernerwerk für Medizinische Technik."

1970s - 1980s:

• 1974: Siemens scientists present the company's first tomographic X-ray image of a human head at the Radiological Society of North America meeting in Chicago.

• 1975: Siemens releases its first commercial CT scanner, the Siretom.

• Late 1970s: Siemens' research laboratories work on MRI prototypes.

• February 1980: Siemens obtains its first MRI image of a human head (Dr. Alexander Ganssen).

• August 1983: Siemens commissions its first commercial MRI scanner, the MAGNETOM, at the Mallinckrodt Institute of Radiology in St. Louis, USA.

• 1980s: Siemens advances angiography, fluoroscopy, and invests in nuclear medicine, opening an R&D facility in Illinois.

• Late 1980s: Siemens develops the Syngo imaging software platform and introduces early Picture Archiving and Communication Systems (PACS).

1990s - 2000s:

• 1992: Siemens establishes its first manufacturing site in China (Shanghai) for X-ray and ultrasound systems.

• 1998: Siemens introduces the first track-based lab automation system, the Advia LabCell.

• Early 2000s: Siemens opens advanced production facilities in Shenzhen (MRI magnets) and Wuxi (X-ray tubes) in China. Expansion also occurs in India and the USA (Illinois for molecular imaging).

• 2000: Siemens acquires Shared Medical Systems (SMS), a U.S. hospital information systems company.

• 2000: Siemens unveils the Biograph PET-CT, the first system to physically combine PET and CT scanners in one unit.

• 2006: Siemens announces the acquisition of Diagnostic Products Corporation (DPC) and the Diagnostics Division of Bayer.

• 2007: Siemens further expands its lab portfolio by acquiring Dade Behring.

2000s - 2010s:

• 2005: Siemens first launches its Dual-Source CT scanner as the SOMATOM Definition.

• 2010: Siemens launches the Biograph mMR, the world's first fully integrated PET-MRI scanner.

• 2011: Siemens exits the business of radiation therapy linear accelerators.

• 2014: Siemens sells its hospital IT business to Cerner.

• 2016: Siemens rebrands its healthcare division as Siemens Healthineers.

• 2017: Siemens Healthineers launches a portable ultrasound system priced for primary care settings.

• 2017: Siemens launches the Atellica Solution for high-throughput labs.

• 2018: Siemens Healthineers AG debuts as a publicly listed company on the Frankfurt Stock Exchange.

• 2019: Siemens Healthineers acquires Corindus Vascular Robotics, specializing in robotic-assisted systems for minimally invasive procedures.

• 2020: Siemens introduces the AI-Rad Companion, an AI software suite for automated image analysis.

• August 2, 2020: Siemens Healthineers announces an agreement to acquire Varian Medical Systems for $16.4 billion.

2021:

• April 2021: The acquisition of Varian Medical Systems is completed.

• 2021: Siemens Healthineers receives FDA clearance for the Naeotom Alpha, its next-generation photon-counting CT scanner.

2022 - Early 2025:

• Early 2020s: Siemens Healthineers responds to the COVID-19 pandemic with diagnostic assays and remote service technologies.

• 2022: Siemens Healthineers faces scrutiny for its continued operations in Russia following the invasion of Ukraine.

• August 2024: Siemens Healthineers acquires the diagnostic arm of Advanced Accelerator Applications (AAA) from Novartis, specialising in radiopharmaceuticals.

• Early 2025: Siemens Healthineers continues to focus on developing photon-counting CT, high-field MRI, accessible imaging solutions, advanced lab diagnostics, and integrating AI across its portfolio. The Varian division focuses on innovations like flash radiation therapy and AI-driven treatment planning.

2017

• Summer: Andrew Dudum, a Silicon Valley entrepreneur, conceives the idea for a company to address men's health issues with discretion.

• November 1: Hims officially launches as a direct-to-consumer wellness brand focused on men's health, offering telehealth consultations and discreet shipping of treatments for hair loss (finasteride, minoxidil) and erectile dysfunction (sildenafil).

• First Week: Hims reportedly surpasses $1 million in sales, experiencing significant early demand.

2018

• October: Hims unveils Hers, a dedicated line for women's health and wellness, applying the same model of telehealth and stylish branding to areas like birth control, skincare, and women's hair care. Hers also begins offering emergency contraception.

• Hims & Hers expands its product offerings beyond initial categories to include vitamins and supplements for general wellness and sleep.

2019

• January: Hims & Hers achieves "unicorn" status with a valuation over $1 billion after a Series C funding round.

• Hims products become available in Target stores, marking the brand's first brick-and-mortar presence.

• Andrew Dudum reports that the Hims & Hers platform is seeing two to three thousand patient consultations daily across various categories.

2020

• Early 2020: The COVID-19 pandemic begins, significantly increasing the need for and acceptance of telehealth services.

• Within Days of Lockdowns: Hims & Hers rapidly launches a virtual primary care service at cost to alleviate pressure on the traditional healthcare system.

• Mid-2020: Hims & Hers rolls out online psychiatry services in most states, allowing patients to receive evaluations and prescriptions for mental health conditions.

• Hims & Hers also introduces individual therapy in select states and free anonymous online support groups led by counselors.

• By the end of the year, Hims & Hers is providing psychiatry services in 44 states and therapy in 32 states.

2021

• January: Hims & Hers goes public on the New York Stock Exchange (NYSE) via a SPAC merger, becoming Hims & Hers Health, Inc. (ticker symbol HIMS), raising approximately $280 million and achieving a valuation of around $1.6 billion. The NYSE is adorned with a Hims & Hers banner proclaiming "The future of healthcare."

• Hims & Hers acquires Apostrophe, a personalized teledermatology and online pharmacy service specialising in custom-compounded prescription skincare, for an estimated $150–190 million.

• Hims & Hers continues to expand its product lines across sexual health (e.g., "Hard Mints"), hair care (improved topicals), and skincare.

2022

• Hims & Hers further expands its over-the-counter skincare line through a partnership.

• By late 2022, Hims & Hers reports having facilitated over a million telehealth consultations.

2023

• Early 2023: Hims & Hers appoints a Senior Vice President of Mental Health.

• Actress Kristen Bell partners with Hers as a mental health ambassador.

• Spring: Hims & Hers launches its Weight Management program, initially focusing on conventional strategies.

• Mid-2023: Hims & Hers introduces "Heart Health by Hims," its first foray into cardiovascular health, offering personalised sexual health treatments with integrated cardiovascular support in collaboration with the American College of Cardiology and partnering with Labcorp for convenient lab testing.

• Late 2023: Hims & Hers announces "MedMatch," an AI-powered tool to provide clinical decision support, initially focused on mental health treatment recommendations.

• Hims & Hers begins offering access to compounded semaglutide injections for weight loss at a lower cost than branded options, capitalising on drug shortages.

2024

• Hims & Hers rapidly scales its Weight Loss by Hims & Hers program, including compounded semaglutide, nutritional coaching, and exercise guidance.

• September: Hims & Hers announces a special initiative offering compounded GLP-1 treatments for as low as $99 per month for "community heroes."

• Hims & Hers acquires a peptide compounding facility in California to strengthen its supply chain for injectable medications.

• Dr. Jessica Shepherd is appointed Chief Medical Officer for the Hers brand.

• Hims & Hers launches the Hims & Hers Health Collective, an ambassador program for customers.

• Hims & Hers achieves profitability for the first time.

• Hims & Hers experiences a surge in inquiries about its weight loss program following a controversial Super Bowl TV commercial criticising the traditional healthcare system for its approach to obesity.

• Two U.S. Senators express concern to the FDA about the content of the Super Bowl ad.

• Hims & Hers adds pharmacy and regulatory experts to its leadership team.

• Hims & Hers pilots a program with a major hospital system for patient referrals.

2025

• February: The FDA officially declares the shortage of semaglutide over, impacting the ability of compounding pharmacies to produce it at scale. Hims & Hers acknowledges this potential change in its weight loss offerings.

• February: Hims & Hers acquires Trybe Labs (Sigmund Labs), an at-home diagnostics company with a CLIA-certified lab, to enable at-home blood testing and expand into new clinical categories.

• March: Hims & Hers announces it will discontinue the Apostrophe brand and integrate its dermatology services fully into the core Hims & Hers platform, leading to some staff layoffs.

1919:

• Takeshi Yamashita establishes Takachiho Manufacturing Co., Ltd. in Tokyo on October 12th, with the goal of producing high-quality, Japanese-made microscopes.

1920:

• Takachiho Manufacturing Co., Ltd. (soon to be known as Olympus) unveils the Asahi microscope, Japan’s first domestically manufactured microscope.

1920s-1930s:

• Olympus expands its product range and technical expertise, producing more advanced microscopes like the Showa GK immersion microscope (1927).

• Olympus ventures into photographic lenses under the "Zuiko" brand.

1936:

• Olympus releases its first consumer camera, the Semi-Olympus.

1949:

• Takachiho Manufacturing Co., Ltd. is renamed Olympus Optical Co., Ltd.

Late 1940s:

• Surgeons at the University of Tokyo Hospital conceive the idea of a camera to photograph the inside of the stomach and approach Olympus.

• Olympus engineers begin developing the gastrocamera under the leadership of Tatsujiro Kirschner.

1950:

• Olympus unveils the world’s first practical gastrocamera, the GT-1, at a meeting of the Japan Surgical Association. Dr. Shigeru Kanai is among the first to use it.

1950s:

• Olympus continues to refine the gastrocamera, improving image quality and ease of use.

1957:

• Olympus introduces the GT-III gastrocamera, featuring sharper photos of the stomach lining.

Early 1960s:

• Olympus engineers begin experimenting with fiber-optic endoscopes.

1964:

• Olympus achieves a breakthrough by attaching a fiber-optic bundle to a modified gastrocamera, allowing live viewing and photography.

• Winter & Ibe introduces fibre-optic illumination in urology scopes.

Mid-1960s:

• Olympus releases its first fully flexible fibre gastroscope, enabling real-time observation and biopsies.

1966:

• Olympus, working with Dr. Shigeto Ikeda and Machida, co-develops the world’s first flexible fibreoptic bronchoscope. Dr. Ikeda presents it in Copenhagen.

Late 1960s:

• Fibre bronchoscopes become widely used in hospitals.

June 1969:

• Dr. William Wolff and Dr. Hiromi Shinya perform one of the world’s first total colonoscopies using a prototype colonoscope developed in collaboration with Olympus.

• Olympus has a dedicated colonoscope in development, incorporating feedback from Wolff and Shinya.

Around 1971:

• Dr. Hiromi Shinya, working with Olympus, develops a wire loop snare-cautery device for endoscopic polyp removal.

1969-1972:

• Wolff and Shinya perform over 1,600 colonoscopies and remove hundreds of polyps using Olympus colonoscopes and snares.

1973:

• Wolff and Shinya publish their landmark findings on colon polyps and endoscopic removal in the New England Journal of Medicine.

1975:

• Olympus establishes a partnership with Winter & Ibe GmbH, gaining access to their line of surgical endoscopes in exchange for optical systems.

Late 1970s:

• Olympus begins selling laparoscopes and other rigid scopes under its brand.

1970s:

• KeyMed Ltd. becomes a key distributor and partner for Olympus endoscopes in Europe.

• Olympus begins investing more heavily in its medical division due to the success of endoscopy.

1979:

• Olympus acquires Winter & Ibe GmbH, establishing "Olympus Winter & Ibe" as its European manufacturing base for surgical endoscopes and instruments.

• Olympus acquires majority ownership of KeyMed Ltd.

• Olympus opens a major repair and service centre in San Jose, California.

Early 1980s:

• Olympus can offer a comprehensive suite of flexible and rigid endoscopes and related instruments.

1983:

• Olympus merges its U.S. operations into a unified subsidiary, Olympus Corporation of America.

1983-1985:

• Olympus develops its first video endoscope system.

1985:

• Olympus introduces its first complete Endoscopic Video Information System (EVIS), the first generation video endoscope setup.

1987:

• Olympus fully acquires KeyMed Ltd.

• Olympus establishes an office in Beijing, China.

• Laparoscopic cholecystectomy begins to gain popularity, contributing to a boom in minimally invasive surgery.

1989:

• Olympus launches the EVIS 100 system.

1990:

• Olympus launches the EVIS 200 system.

1992:

• Olympus introduces EndoALPHA, an integrated operating room concept for minimally invasive surgeries.

2002:

• Olympus launches the EVIS LUCERA system (EVIS EXERA in some regions), the world’s first high-definition (HD) endoscope platform.

• Olympus launches the Visera line, the world’s first integrated video system for surgical endoscopy usable across various departments.

Around 2005:

• Olympus introduces Narrow Band Imaging (NBI) technology.

2008:

• Olympus acquires Gyrus Group, a UK-based maker of surgical energy devices and endoscopes.

2010:

• Olympus acquires Spiration Inc., a U.S. company developing the Spiration Valve for severe emphysema.

2011:

• Michael Woodford, the British CEO of Olympus, goes public with allegations of a major accounting fraud within the company. Tsuyoshi Kikukawa resigns as chairman.

2012:

• Hiroyuki Sasa becomes the new president of Olympus, initiating a transformation program focused on medical technology.

• Olympus Surgical Technologies America is created, integrating Gyrus’s facilities.

2015:

• Sony Olympus Medical Solutions introduces one of the first surgical endoscopy systems with true 4K resolution.

2019:

• Olympus celebrates its 100th anniversary. Yasuo Takeuchi is President and CEO. Olympus takes a minority stake in Medineering, a robotic endoscope holder company.

2020:

• Olympus exits the traditional camera business, selling its imaging division.

• Olympus launches the ENDO-AID AI platform in its latest endoscopy system, the EVIS X1.

• Olympus spins off its scientific microscope division.

2021:

• Olympus rolls out H-SteriScope™ single-use bronchoscopes, entering the single-use endoscopy market.

2022:

• Olympus's spun-off scientific microscope division is rebranded as Evident Corporation.

2023:

• Olympus agrees to acquire Odin Vision, a British startup focused on cloud-based AI for endoscopy.

• Stefan Kaufmann's tenure as CEO of Olympus is cut short, indicating stronger corporate governance.

Present Day (2020s):

• Olympus focuses on advanced imaging (4K, 3D), AI-powered diagnostics, single-use devices, and therapeutic innovations in endoscopy and minimally invasive surgery.

• The company maintains a leading position in the global endoscope market.